Technology
FT: AstraZeneca and Bristol-Myers Squibb plan $400bn merger
Despite months-long discussions, talks could still fall apart, reports the Financial Times. Read more: FT: AstraZeneca and Bristol-Myers Squibb plan $400bn merger
Despite months-long discussions, talks could still fall apart, reports the Financial Times. Read more: FT: AstraZeneca and Bristol-Myers Squibb plan $400bn merger